Ignite Creation Date:
2024-05-06 @ 4:28 PM
Last Modification Date:
2024-10-26 @ 2:11 PM
Study NCT ID:
NCT04998227
Status:
RECRUITING
Last Update Posted:
2024-04-17
First Post:
2021-08-03
Brief Title:
Latent TGF-β-binding Proteins Affect the Fibrotic Process in Renal Impairment and Cardiac Dysfunction
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
Latent TGF-β-binding Proteins Affect the Fibrotic Process in Renal Impairment and Cardiac Dysfunction
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The project is planed to explore the impact of LTBP4 and other matrix protein and potentially related biomarkers on renal outcomes cardiac outcomes and all-cause mortality in patients with suspected acute coronary syndrome ACS
Detailed Description:
The investigators will collect the blood samples from patients with suspect ACS LTBP4 will be the first matrix protein that are going to understand Upon hospital arrival blood samples around 8 ml will be collected and the 2nd collection will be two weeks to one month after the event The third collection will be one year later In the between if any ACS event develop blood samples will be collected as protocols
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None